SPOTLIGHT -
Dr. Borello on Treating Indolent Versus Aggressive Relapsed Multiple Myeloma
Ivan M. Borrello, MD, discusses treatment for patients with indolent versus aggressive relapsed multiple myeloma.
Read More
Dr. Borrello Sheds Light on the Multiple Myeloma Treatment Paradigm
Ivan M. Borrello, MD, discusses the current multiple myeloma treatment paradigm.
Dr. Borrello on Selinexor in Penta-Refractory Multiple Myeloma
Ivan M. Borrello, MD, associate professor of oncology, Johns Hopkins Medicine, discusses the use of selinexor (Xpovio) in the treatment of patients with penta-refractory multiple myeloma.
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
